Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $4.54 million. The enterprise value is $3.97 million.
Important Dates
The next estimated earnings date is Wednesday, May 14, 2025.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 21.48 million shares outstanding. The number of shares has increased by 194.35% in one year.
Current Share Class | 21.48M |
Shares Outstanding | 21.48M |
Shares Change (YoY) | +194.35% |
Shares Change (QoQ) | +82.54% |
Owned by Insiders (%) | 0.72% |
Owned by Institutions (%) | 4.90% |
Float | 21.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | -21.28 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.87
Current Ratio | 0.87 |
Quick Ratio | 0.51 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -353.99 |
Financial Efficiency
Return on equity (ROE) is -714.95% and return on invested capital (ROIC) is -365.88%.
Return on Equity (ROE) | -714.95% |
Return on Assets (ROA) | -204.98% |
Return on Invested Capital (ROIC) | -365.88% |
Return on Capital Employed (ROCE) | 4,983.28% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.11M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.62% in the last 52 weeks. The beta is 0.87, so Oragenics's price volatility has been lower than the market average.
Beta (5Y) | 0.87 |
52-Week Price Change | -85.62% |
50-Day Moving Average | 0.28 |
200-Day Moving Average | 0.57 |
Relative Strength Index (RSI) | 24.46 |
Average Volume (20 Days) | 325,736 |
Short Selling Information
The latest short interest is 312,636, so 1.46% of the outstanding shares have been sold short.
Short Interest | 312,636 |
Short Previous Month | 1.48M |
Short % of Shares Out | 1.46% |
Short % of Float | 1.47% |
Short Ratio (days to cover) | 0.69 |
Income Statement
Revenue | n/a |
Gross Profit | -4.11M |
Operating Income | -10.56M |
Pretax Income | -19.52M |
Net Income | -10.57M |
EBITDA | -10.53M |
EBIT | -10.56M |
Earnings Per Share (EPS) | -$1.60 |
Full Income Statement Balance Sheet
The company has $864,840 in cash and $328,528 in debt, giving a net cash position of $536,312 or $0.02 per share.
Cash & Cash Equivalents | 864,840 |
Total Debt | 328,528 |
Net Cash | 536,312 |
Net Cash Per Share | $0.02 |
Equity (Book Value) | -211,885 |
Book Value Per Share | -0.02 |
Working Capital | -211,885 |
Full Balance Sheet Cash Flow
Operating Cash Flow | -8.60M |
Capital Expenditures | n/a |
Free Cash Flow | -8.60M |
FCF Per Share | -$0.40 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |